In the early treatment regimen, SCD ablation resulted in a substantial attenuation in tumour growth, while tumours in the untreated cohort, or the doxycycline-treated mice implanted with DU145 cells expressing non-targeting controls, continued to expand (Fig. 7a). This evidence concerns the gene SCD and neoplasm.